MYC and plasma cell myeloma: Small molecule inhibitors of BET bromodomain proteins (JQ1, iBET) have recently been shown to attenuate MYC-driven oncogenic signalling in lymphoma and myeloma (Delmore et al, 2011; Mertz et al, 2011; Zuber et al, 2011).